On ECHEMI
Home > Drugs > Shandong Shenglu Pharmaceutical Co., Ltd.
Shandong Shenglu Pharmaceutical Co., Ltd.
  • Founded in:

    2001-12-27
  • Country:

    China China
  • Address:

    North end of Sihe Road, Sihe Office, Sishui County
  • Tax NO.:

    91370831678104460B
  • Registered Funds:

    1.2 million yuan
  • Website:

  • Email:

Related Drugs
Clindamycin Phosphate Injection
Clindamycin phosphate.
Name Description Content CAS NO. Registered Holders
Clindamycin phosphate

This product is a chemical semi-synthetic clindamycin derivative with no antibacterial activity in vitro. It is hydrolyzed into clindamycin to exert its pharmacological activity after entering the body. Its antibacterial spectrum, antibacterial activity and therapeutic effect are the same as those of clindamycin, but its fat solubility and permeability are better than those of clindamycin. It can be injected intramuscularly and administered intravenously. Its antibacterial effect is 4 to 8 times stronger than that of lincomycin, with good absorption and high bone concentration, and good efficacy against anaerobic infections. It has strong antibacterial activity mainly against Gram-positive cocci (such as Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, etc.) and anaerobic bacteria (such as Clostridium, Bacteroides, etc.).

More

This product is a chemical semi-synthetic clindamycin derivative with no antibacterial activity in vitro. It is hydrolyzed into clindamycin to exert its pharmacological activity after entering the body. Its antibacterial spectrum, antibacterial activity and therapeutic effect are the same as those of clindamycin, but its fat solubility and permeability are better than those of clindamycin. It can be injected intramuscularly and administered intravenously. Its antibacterial effect is 4 to 8 times stronger than that of lincomycin, with good absorption and high bone concentration, and good efficacy against anaerobic infections. It has strong antibacterial activity mainly against Gram-positive cocci (such as Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, etc.) and anaerobic bacteria (such as Clostridium, Bacteroides, etc.).

24729-96-2 33
Diammonium Glycyrrhizinate Injection
The main ingredient of this product is diammonium glycyrrhizinate. The excipients are water for injection and sodium hydroxide. Chemical name: 20β-carboxyl-11-oxo-n-oleanol-12-ene-3β-yl-2-O-β-D-glucopyranosiduronic acid-α-D-glucopyranosiduronic acid diammonium salt.
Name Description Content CAS NO. Registered Holders
Diammonium glycyrrhizinate

It has certain anti-inflammatory, liver cell membrane protection and liver function improvement effects. It can reduce the increase of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) caused by carbon tetrachloride, thioacetamide and D-aminogalactic acid, reduce the damage of D-aminogalactic acid to the liver and improve the chronic damage of immune factors to the liver.

More

It has certain anti-inflammatory, liver cell membrane protection and liver function improvement effects. It can reduce the increase of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) caused by carbon tetrachloride, thioacetamide and D-aminogalactic acid, reduce the damage of D-aminogalactic acid to the liver and improve the chronic damage of immune factors to the liver.

79165-06-3 35
Gastrodin injection
The main ingredient of this product is: Gastrodin. Its chemical name is: 4-hydroxyphenyl-β-D-pyranoglucoside.
Name Description Content CAS NO. Registered Holders
Gastrodin

Restores the imbalance between the excitation and inhibition processes of the cerebral cortex, and has central inhibitory effects such as sedation, hypnosis and analgesia

More

Restores the imbalance between the excitation and inhibition processes of the cerebral cortex, and has central inhibitory effects such as sedation, hypnosis and analgesia

62499-27-8 7
Cycloadenosine meglumine injection
The main ingredient of this product is cyclic adenosine monophosphate meglumine, which is the salt of cyclic adenosine monophosphate and meglumine (molar ratio 1:1).
Name Description Content CAS NO. Registered Holders
cAMP

Non-digitalis cardiotonic agent with positive inotropic effect, can enhance myocardial contractility, improve cardiac pumping function, dilate blood vessels, reduce myocardial oxygen consumption; improve myocardial cell metabolism, protect ischemic and hypoxic myocardium; can improve sinoatrial node P cell function.

More

Non-digitalis cardiotonic agent with positive inotropic effect, can enhance myocardial contractility, improve cardiac pumping function, dilate blood vessels, reduce myocardial oxygen consumption; improve myocardial cell metabolism, protect ischemic and hypoxic myocardium; can improve sinoatrial node P cell function.

0
Ondansetron Hydrochloride Injection
Ondansetron Hydrochloride
Name Description Content CAS NO. Registered Holders
Ondansetron hydrochloride

This product is a selective 5-HT3 receptor antagonist. Its mechanism of action may be to antagonize the 5-HT3 receptors in the peripheral vagus nerve endings and central chemoreceptor areas, thereby blocking the vomiting reflex caused by factors such as chemotherapy and surgery that promote the release of 5-HT from intestinal chromaffin cells and excite the vagus afferent nerves. This product has high selectivity and no side effects such as extrapyramidal reactions and excessive sedation.

More

This product is a selective 5-HT3 receptor antagonist. Its mechanism of action may be to antagonize the 5-HT3 receptors in the peripheral vagus nerve endings and central chemoreceptor areas, thereby blocking the vomiting reflex caused by factors such as chemotherapy and surgery that promote the release of 5-HT from intestinal chromaffin cells and excite the vagus afferent nerves. This product has high selectivity and no side effects such as extrapyramidal reactions and excessive sedation.

103639-04-9 26
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.